RICE HALL JAMES & ASSOCIATES, LLC OBIO — ORCHESTRA BIOMED HLDGS INC

Ownership history in RICE HALL JAMES & ASSOCIATES, LLC  ·  3 quarters on record

AI Ownership Summary

RICE HALL JAMES & ASSOCIATES, LLC reported ORCHESTRA BIOMED HLDGS INC (OBIO) in 3 quarterly 13F filings from 2026 Q1 through 2026 Q3. Peak portfolio weight reached 0.28% in 2026 Q3. The latest visible filing shows OBIO at 0.28% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings.

What this OBIO ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was RICE HALL JAMES & ASSOCIATES, LLC's position in ORCHESTRA BIOMED HLDGS INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q3

OBIO was reported at 0.28% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
0.28% in 2026 Q3

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2026 Q1 to 2026 Q3

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

How RICE HALL JAMES & ASSOCIATES, LLC held OBIO — position size vs. price
% of Fund (quarterly)    OBIO price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 3 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q3 ADDED — — — 837,869 +413,869 +97.6% 0.28% $5.2M 2026-11-16 $7.12
2026 Q2 ADDED — — — 424,000 +404,999 +2131.5% 0.09% $1.8M 2026-08-07 $4.24
2026 Q1 INITIATED — — — 19,001 — — 0.00% $81K 2026-05-15 $3.72

FAQ About RICE HALL JAMES & ASSOCIATES, LLC and OBIO

These are the practical questions this page is built to answer before you even open the full history table.

How long has RICE HALL JAMES & ASSOCIATES, LLC reported owning OBIO?

RICE HALL JAMES & ASSOCIATES, LLC reported OBIO across 3 quarterly 13F filings, from 2026 Q1 through 2026 Q3.

What was the largest reported OBIO position in RICE HALL JAMES & ASSOCIATES, LLC's portfolio?

The largest reported portfolio weight for OBIO was 0.28% in 2026 Q3.

What is the latest reported OBIO position on this page?

The most recent filing on this page is 2026 Q3, when RICE HALL JAMES & ASSOCIATES, LLC reported 837,869 shares, equal to 0.28% of portfolio, with an estimated market value of $5.2M.

What does the chart on this OBIO ownership page compare?

The chart compares RICE HALL JAMES & ASSOCIATES, LLC's quarterly OBIO portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

← Back to RICE HALL JAMES & ASSOCIATES, LLC Holdings